Literature DB >> 4608289

Chemical immunosuppression and human cancer.

I Penn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4608289     DOI: 10.1002/1097-0142(197410)34:8+<1474::aid-cncr2820340820>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  Chronic myelomonocytic leukemia and primary Sjögren's syndrome.

Authors:  T Ponge; F Champetier de Ribes; A Ponge; R Garand; S Cottin
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

2.  Tumour-associated antigens.

Authors:  R W Baldwin
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-05-20

3.  A peripheral blood biomarker estimates probability of survival: the neutrophil-lymphocyte ratio in noncancer patients.

Authors:  Jeremy L Davis; Vitor Moutinho; Katherine S Panageas; Daniel G Coit
Journal:  Biomark Med       Date:  2016-08-18       Impact factor: 2.851

4.  Lung carcinoma after radiotherapy and chemotherapy for Hodgkin's disease.

Authors:  R A Matthay; S K Zorn; M S Mitchell; R J Papac
Journal:  Thorax       Date:  1977-10       Impact factor: 9.139

Review 5.  Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.

Authors:  D Fritze; D H Kern; Y H Pilch
Journal:  Klin Wochenschr       Date:  1976-09-15

6.  Inhibitors of C5 complement enhance vaccinia virus oncolysis.

Authors:  D Magge; Z S Guo; M E O'Malley; L Francis; R Ravindranathan; D L Bartlett
Journal:  Cancer Gene Ther       Date:  2013-05-10       Impact factor: 5.987

7.  Hepatocellular carcinoma complicating chronic granulomatous hepatitis.

Authors:  W M Melia; H Calvey; B Portmann; R Williams
Journal:  J Clin Pathol       Date:  1983-09       Impact factor: 3.411

8.  Immunologic response and factors affecting its assessment.

Authors:  J A Moore; R E Faith
Journal:  Environ Health Perspect       Date:  1976-12       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.